Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma.
Richard Turkington(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Ken Arthur(Queen's University Belfast), Robert O’Neill(UNSW Sydney), Tim Underwood(Southampton General Hospital), Jaine K. Blayney(Queen's University Belfast), Stephen McQuaid(Queen's University Belfast), Rebecca C. Fitzgerald(Cancer Research UK), Jacqueline A. James(Queen's University Belfast), Rosalie Douglas(Queen's University Belfast), Steven M. Walker(Almac (United Kingdom)), Andrena McCavigan(Almac (United Kingdom)), Fergus Noble(University Hospital Southampton NHS Foundation Trust), Shona MacRae(Hutchison/MRC Research Centre), Laura A. Knight(Almac (United Kingdom)), Leanne Stevenson(Queen's University Belfast), Damian McManus(Belfast Health and Social Care Trust), Jan Bornschein(John Radcliffe Hospital), Martin Eatock(Queen's University Belfast), Paul Harkin
Cited by 0
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
|Gut|2013|1.3k
Oesophageal cancer
|Nature Reviews Disease Primers|2017|1.1k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770